Doctors and their patients can now consider this class of medications not only for the treatment of obesity and to control blood sugar, but also to benefit mens reproductive health. Implications for Clinical Practice The study underscores the broader systemic benefits of GLP-1-based therapies and other anti-obesity agents, particularly in populations at high risk of endocrine dysfunction
Because the experimental hypotheses and study results were a continuation of our previous project, data analysis was also performed based on this division
10.1016/j.bbr.2016.06.004 30
To ensure data integrity, we conducted a thorough review to eliminate potential duplicates, defined as records sharing at least three out of four key fields: event date, age, sex, and reporters country
In contrast, Wegovy is tailored for chronic weight management
Methods Study design and data source This was a Region-wide, retrospective, longitudinal, comparative effectiveness study